VENUS MEDTECH-B (02500) Plans to Sell Hangzhou Property for Approximately RMB375 Million

Stock News
11/11

VENUS MEDTECH-B (02500) announced on November 11, 2025, that the company intends to sell a property (including an industrial park under construction on Plot 1 and Plot 2, along with the associated land use rights) to Hangzhou Binjiang Urban Construction Development Co., Ltd. for a total consideration of approximately RMB375 million.

Plot 1 is located in Binjiang District, Hangzhou (Hangzheng Gong [2021]-22), designated for industrial and commercial development. It has a total land area of approximately 30,732.00 square meters and a planned total construction area of about 138,813.29 square meters (including 82,838.54 square meters of above-ground construction area and 55,974.75 square meters of underground construction area).

Plot 2, also situated in Binjiang District, Hangzhou (Hangzheng Gong [2021]-22), is similarly designated for industrial and commercial development. It shares the same land area and planned construction area as Plot 1.

Considering the group's liquidity position, current real estate market conditions, and business strategy, the board believes the sale presents an opportunity to monetize the property investment at a fair and reasonable price. The transaction will provide immediate cash inflow, alleviate overall debt pressure, and supplement working capital. Additionally, the sale is expected to enhance the group's financial credibility, optimize asset allocation, and allow resources to be focused on core operations.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10